Recombinant Vaccines Market to Reach $21 Billion by 2026; Increasing Number of Regulatory Approvals to Aid Growth, says Fortune Business Insights™
13. Januar 2020 07:57 ET
|
Fortune Business Insights
Pune, Jan. 13, 2020 (GLOBE NEWSWIRE) -- The global Recombinant Vaccines Market size is projected to reach USD 21.00 billion by the end of 2026. The advancements in molecular genomics have opened up...